When the Cost of Diabetes Hurts More Than the Disease: Three Women’s Stories from Iran

Three women in Iran describe how soaring treatment costs, social stigma, and inadequate healthcare support turn diabetes into a struggle for financial security, dignity, and survival.

“I think the staggering cost of treating diabetes is more painful than the disease itself.”

These are the words of Maral, a 44-year-old homemaker. Her story, alongside those of two other women interviewed for this report, reveals how a chronic illness, intertwined with economic hardship, gender, and social attitudes, becomes not only a medical condition but also a struggle over livelihood and identity. Their experiences show how rising medication and blood glucose test strip costs, combined with social stigma and the absence of institutional support, leave women struggling to continue treatment while enduring social judgement and sacrificing their financial security.

Diabetes in Iran is no longer a rare condition or one associated primarily with older people. According to figures cited in this report, approximately 11.4% of the population over the age of 25, nearly 5.5 million people, have diabetes, while millions more are at risk of developing it. Yet what medical records rarely capture is the daily financial burden of managing the condition: the cost of insulin, which has multiplied amid sanctions; blood glucose test strips, which some patients need at a rate of one packet a week; and health insurance that fails to cover all the expenses. Against this backdrop, three women share their different experiences of living with the same disease.

Growing Up with Diabetes and Social Stigma

Farzaneh, a literature student, was 12 when she first developed symptoms: severe weakness and fatigue, constant thirst, weight loss, and bedwetting. At a family gathering, a doctor who was present advised her mother to have her tested. After several tests, she was diagnosed with type 1 diabetes. Farzaneh says there was no family history of the disease, and because awareness of diabetes was far more limited at the time, her family was terrified. She felt as though something unfamiliar had taken hold inside her body, something she knew nothing about and feared might grow until it took her life. Her mother, she recalls, was constantly anxious, and the family’s behaviour towards her changed. Farzaneh began to feel as though there was something fundamentally wrong with her body and that she needed constant supervision to prevent her blood sugar from falling too low or rising too high. Being watched so closely was distressing, especially because she had a strong craving for sweets, which were now forbidden in the house.

The difficulties did not end there. Farzaneh was also terrified of injections. Yet she had to administer insulin herself whenever her mother was unavailable, particularly at school. One day, while injecting insulin in a corridor near the toilets, a classmate saw her. Farzaneh recalls that they were both startled. She burst into tears, and the other girl immediately walked away. Afterwards, she felt ashamed. Other children whispered among themselves and began distancing themselves from her, as though they did not want to be near someone who was ill.

Recalling that moment, Farzaneh says:

“We were both startled. I burst into tears, and she left immediately. Afterwards, I felt ashamed, as though I had done something wrong or some terrible defect of mine had been exposed.”

Farzaneh says her family had told her not to speak to anyone about her diabetes, advice that, whether intentionally or not, made her feel vulnerable and inadequate. Looking back, she now realises that many of her parents’ well-intentioned attempts to protect her caused considerable harm. The turning point came when she discovered a diabetes association, where, for the first time, she met people who had been living with the same condition for years. By sharing their experiences, offering practical advice, and helping her develop a healthier daily routine, they transformed her understanding of diabetes. Farzaneh believes that, for children diagnosed at an early age, regular participation in such associations can be enormously valuable, offering emotional support, practical knowledge, and reassurance alongside medical treatment.

Farzaneh’s experience is more than a childhood memory; it reflects a broader pattern. Delayed diagnosis of type 1 diabetes in children remains a challenge for Iran’s healthcare system. In some cases, the first recognised signs are not thirst or weight loss but a loss of consciousness or even a coma. Farzaneh was fortunate that a doctor happened to be present at the gathering. Many children from families with limited knowledge of the disease or insufficient financial resources are not so fortunate. According to the head of the Iranian Diabetes Society, 90% of diabetes management depends on self-care and education, rather than medication alone. Yet unlike in many other countries, health insurance in Iran does not cover the cost of such education, forcing diabetes associations to rely on charitable donations and public contributions to fund their programmes.

When Treatment Becomes More Burdensome Than the Disease

Maral, a 44-year-old homemaker, had a family history of type 2 diabetes. Her father and paternal uncle both had the disease, and her uncle had died from it. But genetics was not the only factor in her condition. She had struggled with excess weight for years, and the more those around her tried to control her stress-related overeating, the stronger her urge to eat became. By her own account, she did not have a healthy lifestyle. Constant stress, physical inactivity, insomnia, and a diet rich in fatty foods and sweets all contributed to her developing diabetes. The first symptoms were tingling sensations in her hands and feet. Her condition eventually became so serious that she nearly lost one of her kidneys, all within the past five years.

For Maral, the financial burden of diabetes became even harder to bear than the illness itself. She needed to abandon unhealthy habits, begin losing weight as soon as possible, follow a healthier diet, and continue taking medication. Every aspect of this process came at a cost. Maral says that within a single year, she spent all the money she had saved to buy a car on medical treatment.

She recalls:

“I remember spending every bit of the money I had saved to buy a car on treatment in that one year.”

Her only income came from the pension she received following her father’s death. She had lost her job some time earlier when the company where she worked downsized its workforce. Her younger sister was a student, and her mother was unable to work. Maral says she often had to turn to friends and acquaintances for help finding insulin, while obtaining some of her other medications meant visiting one pharmacy or supplier after another.

Her experience is also reflected in broader economic figures. According to figures cited in the report, the combined cost of essential diabetes supplies, particularly blood glucose test strips and insulin pens, rose to 4.3 times its previous level over approximately two months, while the price of test strips alone reportedly quadrupled in recent months. An insulin pen was reported to cost approximately 800,000 tomans, and obtaining one had become increasingly difficult. The average annual cost of treating a person with diabetes in eastern Iran has been estimated at $1,153, with significantly higher expenses for those who develop complications. Perhaps the most revealing figures, however, concern the growing gap between medication prices and insurance coverage. In one documented case reported in July 2026, a patient’s out-of-pocket payment for the same insulin prescription increased more than 24-fold between early May and late June, even though the total prescription price rose by approximately 39%. The reason was that the Social Security Organisation’s insurance reimbursement remained unchanged, leaving the patient to cover the entire increase.

But perhaps the most significant aspect of Maral’s story concerns the social value placed on the body of a person living with diabetes. She says many people still hold deeply prejudiced views about the condition, believing that someone with diabetes should not marry because they would impose substantial financial costs on their spouse or might never give birth to a healthy child. Maral had several suitors who withdrew after learning about her diabetes and her family’s history of the disease, often offering other excuses for their decision. According to her, misconceptions about diabetes place enormous psychological pressure on women. Even as they struggle to manage their health, they must endure the additional emotional burden of other people’s reactions.

Research has also documented experiences of this kind. A 2025 study published in BMC Public Health, involving 432 patients with type 2 diabetes in Ardabil, northwestern Iran, found that women and unmarried participants reported higher levels of perceived social stigma. The researchers suggested that this may reflect deeper cultural attitudes that stigmatise women with chronic illnesses and regard illness as a potential obstacle to marriage. The same study identified a significant inverse relationship between perceived stigma and treatment adherence: higher levels of stigma were associated with lower levels of adherence to treatment. In other words, social attitudes do not merely cause psychological suffering; they can also make managing the condition more difficult.

Without Insurance, a Diabetes Association Becomes a Lifeline

Shirin, a 35-year-old seamstress and mother of one, was still in secondary school when she was diagnosed with diabetes. At the time, she was also working part-time in a shop to help support her family. One day, she fainted and was taken to hospital, where tests revealed that she had diabetes. Shirin recalls that she came from a large family with limited financial resources. At that moment, all she could think about was how they would pay the hospital bills and cover the costs of medication and treatment. The family had no health insurance to help with the expenses, and none of them knew much about the disease. She remembers being extremely frightened.

The first doctor she saw referred her to a diabetes association. Shirin says the financial assistance, medical advice, and companionship of people with similar experiences helped her learn to manage the condition:

“If I hadn’t found the association and the friends I made there, I don’t think I would have made it this far.”

Shirin identifies two widespread misconceptions that have made her daily life more difficult. The first is the assumption that people with diabetes must be gluttonous or have developed the disease because they consumed too much sugar and too many sweets. In reality, she explains, diabetes cannot simply be reduced to eating habits or individual choices. Different forms of the disease have different causes and risk factors, including genetic predisposition, while factors such as physical activity and, in the case of gestational diabetes, pregnancy can also be relevant. Stress and anxiety may further complicate blood glucose management. She considers it deeply unfair to blame people for developing diabetes and hold them personally responsible for their condition. The second misconception is that diabetes is contagious, a belief that creates particular difficulties for people who want to marry. Shirin herself has been married for years. Her husband knew about her condition before they married, and they have a healthy child together. She stresses that the belief that diabetes is contagious is entirely false and unscientific, yet such misconceptions can make life difficult for thousands of people living with the disease.

Shirin’s story illustrates how, in the absence of adequate public support, civil society organisations have become the only source of assistance for some patients. Since 1991–92, a charitable association supporting people with diabetes in Iran has provided more than 10,000 patients with free medical consultations, medication, and blood glucose testing, financing these services through a combination of government assistance and charitable donations. Yet such support remains fragmented and cannot replace a comprehensive public policy that treats access to insulin and blood glucose test strips as a right of citizenship rather than a commodity available only to those who can afford it.

Taken together, these accounts demonstrate that managing diabetes in Iran is not simply a clinical matter but a socioeconomic struggle whose burden falls disproportionately on women, children, and low-income families. Farzaneh faced fear, misinformation, and stigma as a child. Maral spent the money she had saved for a car on treatment and experienced rejection by prospective marriage partners. Shirin was hospitalised without health insurance and found her only reliable support through a diabetes association. Behind all three stories are the same escalating costs: insulin whose price has multiplied, blood glucose test strips needed at a rate of one packet a week but increasingly unaffordable on a family’s pension income, and health insurance that, even when available, fails to bridge the growing financial gap.

What distinguishes these experiences from a purely economic account is the invisible cost to personal identity and dignity: feeling as though one’s body is defective, being ashamed of injecting insulin at school, fearing being seen while eating, and confronting the belief that a person with diabetes is somehow unfit for marriage. Until health policies address these economic and social dimensions together, from comprehensive coverage for insulin and test strips to public education aimed at challenging misconceptions and institutional support for diabetes associations, the stories of women like Farzaneh, Maral, and Shirin will remain accounts of everyday struggle against illness and its financial and social burdens, rather than stories of accessible care and meaningful support.

Weekly Newsletter

Every Thursday, our editors bring you the most important stories from Iran.

Join readers around the world. One email every week. No filler. Unsubscribe anytime.